Thomas L. Rothstein

12.4k citations

205 papers · 10.2k indexed · 4 hit papers · h-index 53

Impact in

Immunology top 0.1%
- T-cell and B-cell Immunology
- Immune Cell Function and Interaction
- Immunotherapy and Immune Responses
- Immune Response and Inflammation
- Immunodeficiency and Autoimmune Disorders
Cancer Research top 1%
- NF-κB Signaling Pathways

Papers in

Immunology 158
- T-cell and B-cell Immunology 103
- Immune Cell Function and Interaction 68
- Immunotherapy and Immune Responses 49
- Immune Response and Inflammation 31
Cancer Research 26
- NF-κB Signaling Pathways 26

Co-authors: Nichol E. Holodick Daniel O. Griffin Ann Marshak‐Rothstein Joseph R. Tumang Michael G. Mage Louise McHugh Robert Howard Linda C. Foote
Journals: The Journal of Immunology (67 papers)The Journal of Experimental Medicine (13 papers)European Journal of Immunology (12 papers)Frontiers in Immunology (11 papers)Cellular Immunology (11 papers)
Partner nations: United States Cuba Spain

In The Last Decade

Thomas L. Rothstein

205 papers receiving 10.0k citations

Hit Papers

align trajectories log scale

Human B1 cells in umbilical cord and adult peripheral blood express the novel phenotype CD20+CD27+CD43+CD70− 2011 · 451 citations

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if any of the following hold:

it has ≥500 total citations;
it reaches ≥1.5× the top-1% citation threshold for papers in the same subfield and year (the threshold is the minimum needed to enter the top 1%, not the average within it);
it reaches the top citation threshold in at least one of its specific research topics.

2011 The Journal of Experimental Medicine
1996 The EMBO Journal
1987 Nature
1977 Journal of Immunological Methods

Peers

Countries citing papers authored by Thomas L. Rothstein

Since Specialization

Citations

This map shows the geographic impact of Thomas L. Rothstein's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Thomas L. Rothstein with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Thomas L. Rothstein more than expected).

Fields of papers citing papers by Thomas L. Rothstein

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Thomas L. Rothstein. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Thomas L. Rothstein. The network helps show where Thomas L. Rothstein may publish in the future.

Co-authors

The 25 scholars most cited alongside Thomas L. Rothstein, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Thomas L. Rothstein Line = papers co-authored together Thomas L. Rothstein links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	A new murine Rpl5 ( uL18 ) mutation provides a unique model of variably penetrant Diamond-Blackfan anemia Blood Advances ·Lei Yu, Philippe Lemay, Manohara Tattekere Nanjappa, E. A. Solop, Morgan Jones, Fatma F. Mohamed, Facultatea de Mecanica, KungumaRaj, Dela Oktaviani, Yu Wang, Manish Chugh, Rami Khoriaty, Qing Li, Renny T. Franceschi, James Douglas Engel, Vesa Kaartinen, Thomas L. Rothstein, Monica J. Justice, Zoha Kibar, Sharon Singh	2021	3
2	Human B-1 and B-2 B Cells Develop from Lin−CD34+CD38lo Stem Cells The Journal of Immunology ·Tâm D. Quách, Thomas J Hopkins, Nichol E. Holodick, Laura Kauvosaari, Tim Manser, Muhammad Reksa Samudera, Thomas L. Rothstein	2016	20
3	Distinctions among Circulating Antibody-Secreting Cell Populations, Including B-1 Cells, in Human Adult Peripheral Blood The Journal of Immunology ·Tâm D. Quách, Nely Rodríguez‐Zhurbenko, Thomas J Hopkins, Xiaoti Guo, Ana Hernández, Wentian Li, Thomas L. Rothstein	2016	80
4	The osteopontin transgenic mouse is a new model for Sjögren's syndrome Clinical Immunology ·Andressa Cristina Gaione Mendes, Jill M. Kramer, Wentian Li, Х. Коцел, Thomas L. Rothstein	2015	21
5	Human B1 cells in umbilical cord and adult peripheral blood express the novel phenotype CD20+CD27+CD43+CD70− The Journal of Experimental Medicine ·Daniel O. Griffin, Nichol E. Holodick, Thomas L. Rothstein Hit paper breakdown →	2011	451
6	Fas Apoptosis Inhibitory Molecule Expression in B Cells Is Regulated through IRF4 in a Feed-Forward Mechanism The Journal of Immunology ·Hiroaki Kaku, Thomas L. Rothstein	2009	17
7	Functional Outcome of B Cell Activation by Chromatin Immune Complex Engagement of the B Cell Receptor and TLR9 The Journal of Immunology ·Liliana Busconi, Jason W. Bauer, Joseph R. Tumang, Moh Farih Fahmi, Jaroslaw Mayer-Szary, Lazare Saminski, Christina M. Lau, Ronald B. Corley, Thomas L. Rothstein, Frances E. Lund, Timothy W. Behrens, Ann Marshak‐Rothstein	2007	54
8	B Cell Receptor (BCR) Cross-Talk: IL-4 Creates an Alternate Pathway for BCR-Induced ERK Activation That Is Phosphatidylinositol 3-Kinase Independent The Journal of Immunology ·Х. Коцел, Thomas L. Rothstein	2005	27
9	Cutting Edge: B-1 Cells Are Deficient in Lck: Defective B Cell Receptor Signal Transduction in B-1 Cells Occurs in the Absence of Elevated Lck Expression The Journal of Immunology ·Rubén Francés, Joseph R. Tumang, Thomas L. Rothstein	2005	21
10	B Cell Receptor (BCR) Cross-Talk: CD40 Engagement Enhances BCR-Induced ERK Activation The Journal of Immunology ·Takuya Mizuno, Thomas L. Rothstein	2005	28
11	CD21/CD19 Coreceptor Signaling Promotes B Cell Survival during Primary Immune Responses The Journal of Immunology ·Robert A. Barrington, Ming Zhang, Xuemei Zhong, A. Helena Jonsson, Nichol E. Holodick, Anu Cherukuri, Susan K. Pierce, Thomas L. Rothstein, Michael C. Carroll	2005	38
12	Cutting Edge: Spontaneously Ig-Secreting B-1 Cells Violate the Accepted Paradigm for Expression of Differentiation-Associated Transcription Factors The Journal of Immunology ·Joseph R. Tumang, Rubén Francés, Seung Geun Yeo, Thomas L. Rothstein	2005	93
13	Phosphatidylinositol 3-Kinase-Dependent Mitogen-Activated Protein/Extracellular Signal-Regulated Kinase Kinase 1/2 and NF-κB Signaling Pathways Are Required for B Cell Antigen Receptor-Mediated Cyclin D2 Induction in Mature B Cells The Journal of Immunology ·Jonhny Edison Olivo-Solís, Suana Gordon, E Marcer, Cheryl A. Doughty, Brian R. Schram, Thomas L. Rothstein, Thomas C. Chiles	2004	22
14	NF-κB Is Required for Surface Ig-Induced Fas Resistance in B Cells The Journal of Immunology ·Brian R. Schram, Thomas L. Rothstein	2003	22
15	Cutting Edge: CD40 Engagement Eliminates the Need for Bruton’s Tyrosine Kinase in B Cell Receptor Signaling for NF-κB The Journal of Immunology ·Takuya Mizuno, Thomas L. Rothstein	2003	29
16	Cutting Edge Commentary: Two B-1 or Not To Be One The Journal of Immunology ·Thomas L. Rothstein	2002	69
17	BCR Engagement Induces Fas Resistance in Primary B Cells in the Absence of Functional Bruton’s Tyrosine Kinase The Journal of Immunology ·Joseph R. Tumang, Kaylen M. Holman, Laura A. Solt, Thomas J. Schneider, A. Avoleta, William D. Hastings, Robert T. Woodland, Thomas L. Rothstein	2002	13
18	Cutting Edge: Differential Signaling Requirements for Activation of Assembled Cyclin D3-cdk4 Complexes in B-1 and B-2 Lymphocyte Subsets The Journal of Immunology ·Debra A. Tanguay, A. Avoleta, Cheryl A. Doughty, Salvatore La Porta, Thomas L. Rothstein, Thomas C. Chiles	2001	23
19	c-Rel Is Required for the Protection of B Cells from Antigen Receptor-Mediated, But Not Fas-Mediated, Apoptosis The Journal of Immunology ·Alexander M. Owyang, Joseph R. Tumang, Brian R. Schram, Constance Y. Hsia, Timothy W. Behrens, Thomas L. Rothstein, Hsiou‐Chi Liou	2001	62
20	Peritoneal B cells respond to phorbol esters in the absence of co-mitogen. The Journal of Immunology ·Thomas L. Rothstein, H. Shafeek	1988	55

About Thomas L. Rothstein

Thomas L. Rothstein is a scholar working on Immunology, Cancer Research, Radiology, Nuclear Medicine and Imaging, Immunology and Allergy and Oncology, having authored 205 papers that have together received 10.2k indexed citations. Recurring topics across this work include T-cell and B-cell Immunology (103 papers), Immune Cell Function and Interaction (68 papers), Immunotherapy and Immune Responses (49 papers), Monoclonal and Polyclonal Antibodies Research (36 papers), Immune Response and Inflammation (31 papers), NF-κB Signaling Pathways (26 papers), Cell death mechanisms and regulation (22 papers) and Cytokine Signaling Pathways and Interactions (13 papers). The work is most often cited by research in Immunology (7.1k citations), Cancer Research (1.3k citations), Immunology and Allergy (398 citations), Radiology, Nuclear Medicine and Imaging (1.4k citations) and Genetics (644 citations). Thomas L. Rothstein has collaborated with scholars based in United States, Cuba and Spain. Frequent co-authors include Nichol E. Holodick, Daniel O. Griffin, Ann Marshak‐Rothstein, Joseph R. Tumang, Michael G. Mage, Louise McHugh, Robert Howard, Linda C. Foote, Mark J. Shlomchik and Martin Weigert. Their work appears in journals such as The Journal of Immunology, The Journal of Experimental Medicine, European Journal of Immunology, Frontiers in Immunology and Cellular Immunology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact